Published in
Taylor and Francis Group, Expert Opinion on Drug Metabolism and Toxicology, 1(11), p. 149-174, 2014
DOI: 10.1517/17425255.2015.991713
Links
Tools
Evaluation of the pharmacokinetics, safety and clinical efficacy of ziprasidone for the treatment of schizophrenia and bipolar disorder
This paper was not found in any repository, but could be made available legally by the author.
Full text: Unavailable
Preprint: archiving forbidden
Published version:
archiving forbidden
Data provided by 